Stocklytics Platform
Asset logo for symbol AUPH
Aurinia Pharmaceuticals
AUPH80
$5.71arrow_drop_up1.60%$0.09
Asset logo for symbol AUPH
AUPH80

$5.71

arrow_drop_up1.60%
query_stats

AUPH is not a dividend stock

Therefore Dividends subscore should not be taken into consideration

For certain stocks classified as non-dividend stocks, dividend-related data may not be available or applicable. Non-dividend stocks are those where the company does not regularly distribute dividends to its shareholders.

Why No Data?

Non-dividend stocks typically do not offer regular dividend payments. As a result, there might be no dividend-related information or history for such stocks within our database.

Understanding Non-Dividend Stocks

Non-dividend stocks are characterized by companies that reinvest their profits back into the business for expansion, research, development, or other strategic purposes rather than distributing dividends to shareholders.

What This Means for Investors

Investors in non-dividend stocks often focus on capital appreciation, anticipating the value of their shares to increase over time without relying on dividend income.

Stay Updated

While dividend information may not be available for these stocks, other critical financial metrics and analyses are accessible on Stocklytics to aid in informed investment decisions.

Stock Split History (AUPH)

DateSplitMultipleCumulative
Multiple
Oct 23, 20131:50x0x0

Aurinia Pharmaceuticals (AUPH) Dividends & Splits

Aurinia Pharmaceuticals Inc (AUPH) does not currently offer dividends to its shareholders. As a biopharmaceutical company focused on developing and commercializing therapies to treat autoimmune diseases, Aurinia reinvests its profits into research and development activities. The company's main focus is on its lead drug candidate, voclosporin, which is being evaluated for the treatment of lupus nephritis (LN).

Regarding stock splits, Aurinia Pharmaceuticals Inc (AUPH) has not announced any splits in its history. The company's shares have maintained their value and have not been subject to any adjustments in terms of split ratios. As of now, each share of AUPH represents one unit of ownership in the company.

add Aurinia Pharmaceuticals  to watchlist

Keep an eye on Aurinia Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
Does Aurinia Pharmaceuticals (AUPH) stock pay dividends?

No, Aurinia Pharmaceuticals (AUPH) does not pay dividends. This could indicate that the company is currently focusing on reinvesting its earnings into growth opportunities rather than distributing them as dividends.

help
When was the last Aurinia Pharmaceuticals (AUPH) stock split?

Aurinia Pharmaceuticals (AUPH) has undergone 1 total stock splits. The most recent split was a 1:50 split on 2013 Oct 23, leaving the company with 143.02M shares outstanding. Since the company's inception, the cumulative multiple from splits is 0, indicating the overall effect of all splits on the original share count.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level